优化生物膜抑制剂:在2N氨基化5--2-氨基胺醇中平衡活性和毒性
Lynn Maetens1, Banibrata Maiti2, Freya Cools3
1MiCA Lab, Centre of Microbial and Plant Genetics (CMPG), Department of Microbial and Molecular Systems, KU Leuven, Kasteelpark Arenberg 20, 3001 Leuven, Belgium; Amynas, Euster 104, 2570 Duffel, Belgium.
Bioorganic & medicinal chemistry
|February 26, 2025
概括
氨基化5-aryl-2-aminoimidazole化合物增强了对像大肠杆菌这样的细菌的生物膜抑制. 一种具有n-heptyl链的非化衍生物显示出有前途的广泛活性,具有降低的毒性,适用于抗感染应用.
科学领域:
- 药用化学 医学化学
- 抗菌研究 抗菌研究
- 药物发现 药物发现 药物发现
背景情况:
- 诸如大肠杆菌, Pseudomonas aeruginosa 和 Staphylococcus aureus 等细菌的生物膜形成在医疗保健中构成了重大挑战.
- 已经研究了5-aryl-2-aminoimidazole (5-Ar-2-AI) 衍生物的抗菌性能.
- 修改现有的抗微生物支架是开发新抗感染药物的关键策略.
研究的目的:
- 为了研究氨化对5-aryl-2-aminoimidazole (5-Ar-2-AI) 化合物的生物膜抑制活性的影响.
- 合成和评估一个含有不同替代物的氨基化5-Ar-2-AI衍生物库.
- 评估这些新型化合物作为潜在的抗感染剂的疗效,毒性和基因毒性.
主要方法:
- 氨基化5-Ar-2-AI衍生物的合成,包括n-基链长度的变化和化.
- 对一组临床相关细菌 (大肠杆菌,P. aeruginosa,S. aureus,S. epidermidis,MRSA) 的生物膜抑制活性的评估.
- 使用多个细胞系和初级细胞评估细胞毒性,以及对Capan-1细胞的基因毒性测试和对Caenorhabditis elegans的毒性评估.
主要成果:
- 阿米纳改善了2N替代的5-Ar-2-AI类生物膜抑制活性.
- 化和增加的n-基链长度增强了活性,但也增加了毒性.
- 一种具有n-heptyl组的非基化2N替代氨基化5-Ar-2-AI,表现出具有有利毒性概况的广谱生物膜抑制.
结论:
- 结构修改,特别是氨化和优化的n-基链长度,可以增强5-Ar-2-AI化合物的抗生物膜功效.
- 抗微生物活性和毒性之间的平衡对于开发安全有效的抗感染剂至关重要.
- 已识别的非化n-heptyl衍生物代表了一种有前途的化合物,用于进一步开发抗感染疗法.
相关概念视频
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Biofilms
Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...


